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The Centers for Disease Control and Prevention (CDC) estimates that about 6,000 babies are 
born with Down syndrome (DS) each year in the United States—that is one out of every 691 
babies, making it the most common birth defect in humans. It is a genetic disorder that results 
from being born with an extra chromosome 21 (trisomy 21). In addition to mental retardation and 
abnormal physical development, DS individuals can also suffer from physiological abnormalities 
such as heart defects and leukemia. They experience Alzheimer-like symptoms, accelerated   
aging, and their average age at death is at 49 years old. The majority of trisomy 21 cases 
occurred due to maternal meiotic nondisjunction (NDJ). There are two types of NDJ: M1 NDJ 
and M2 NDJ, nondisjunction in the meiosis I and meiosis II stages respectively. The two types 
differ in their etiology: maternal age, recombination pattern, and environmental factors. This 
thesis is a pilot study using genome-wide association analysis to locate genes that may be 
responsible for the meiotic error. This study has public health significance because it identifies 
potential genes associated with DS susceptibility. It will help enable us to tease apart the 
susceptibility of NDJ into its individual liability factors. Genotype data from 134 Caucasian 
mothers of maternal NDJ cases were examined using the Cochran-Armitage test for trend. Two 
genes were identified to potentially be associated with the difference in NDJ error: SNX13 and 
PRPS1L1. The data were also used to test known genes responsible for altered recombination 
and Alzheimer’s disease and we found suggestive associations between NDJ and RNF212, a 
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gene thought to be associated with meiotic recombination rate, and between NDJ and PSEN1, an 
Alzheimer’s disease-related gene.  
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PREFACE 
This thesis is written assuming the reader has taken at least a college level introductory biology 
course and understand the basics of cell division genetic biology. 
I would like to give my sincere thanks to Dr. Eleanor Feingold for giving me this project 
to work on and have been patiently providing me guidance in completing this thesis. I would like 
to thank Dr. Roslyn Stone and Dr. Lisa Weissfeld for all the help they gave to make my 
graduation possible this December. 
I would like to thank my family for their support—my mom, my dad, and my brother, 
Pete—and my dearest friend and close confident, Kevin. 
This thesis is dedicated to the loving memory of Mickey.  
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1.0  INTRODUCTION 
1.1 TRISOMY 21 
Down syndrome (DS) is the most common birth defect in humans (National Association for 
Down Syndrome, 2012). The Centers for Disease Control and Prevention (CDC) estimates that 
about 6,000 babies are born with the disorder each year in the United States (Parker et al, 2010). 
In other words, the disorder occurs in 1 out of every 691 babies. Signs typically seen include 
mental retardation, hypotonia, and abnormalities of the face, hands, and feet. Individuals with DS 
also often have congenital heart defects, and are prone to have hearing and vision problems, 
weakness in the neck joints, and development of thyroid disease and leukemia. Their aging 
process seems to be accelerated with the average age of death at 49 (Liptak 2008). Heart disease 
and leukemia account for most deaths. However, it has been discovered that they develop 
Alzheimer-like lesions in their brains and show signs of memory loss, further lowering of 
intellect, and personality changes early in age--as early as 30 years old (Kolata, 1985; Liptak, 
2008).  
Development of DS results when an individual is born with three 21 chromosomes, 
termed trisomy 21, instead of having only the usual two 21 chromosomes (one inherited from the 
mother and the other inherited from the father). Trisomy is a type of aneuploidy (having an 
abnormal number of chromosomes) in which there are three copies of a particular chromosome. 
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There can be trisomy of chromosome 16, trisomy of chromosome 18, etc. However, trisomies 
often result in miscarriage. Trisomy 21 is one of the few trisomies in which the babies survive to 
term, even after 80% of fetuses with trisomy 21 are spontaneously aborted (Hook et al., 1995). 
95% of trisomy 21 cases occur due to meiotic nondisjunction (NDJ), and 90% of NDJ error 
happens in the mother (Sherman et al., 2005). The most significant risk factor for NDJ of 
chromosome 21 is the age of the mother at the time of conception (Sherman et al., 2005). As a 
woman ages, the risk for conceiving a child with trisomy 21 increases. The other significant risk 
factor that is molecularly related is altered meiotic recombination patterns (Sherman et al., 2005). 
There are two types of NDJ: M1 NDJ and M2 NDJ, nondisjunction in the meiosis I and 
meiosis II stages respectively. In M1 NDJ, the paired heterozygous 21 chromosomes fail to 
separate during the first meiosis stage, while in M2 NDJ, the homologous sister chromatids of 
one 21 chromosome fail to separate during the second meiosis stage. The etiology for each type 
of NDJ seems different however. Preliminary data from the Atlanta Down Syndrome Project 
suggests that the effect of age on NDJ vary between the two types. There is an increasing risk for 
M2 NDJ when shifted to older maternal ages compared M1 NDJ though this difference is not 
statistically significant (Sherman et al., 2005). The two types of NDJ have also shown to have 
different altered recombination pattern: M1 NDJ is associated with lack of exchange or with a 
single exchange close to the telomere, whereas exchanges occurring very close to the centromere 
(pericentromeric exchange) increase the risk for M2 NDJ (Lamb et al., 1996, 1997, 2005). 
The next questions that could be asked are whether there is a genetic component to 
maternal meiotic NDJ in trisomy 21 and whether that genetic component is associated in any 
way with the previously mentioned two risk factors. A disorder is likely genetically influenced if 
the disorder recurs among genetically related individuals. However, discerning whether there is a 
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pattern of recurrence risk for NDJ among siblings is complicated by several situations: the 
survival of the aneuploid fetus, small sibship size among families, and the age when the mother 
was pregnant with each of the children. Nonetheless, there are case studies reporting the 
recurrence of trisomy 21 among siblings (Der Kaloustian et al., 1987; Neilsen et al., 1988; Al 
Awadi et al., 1999).  
And so what genes might increase the risk for trisomy 21? The process of cell division 
requires an interworking among a complex variety of structural cell components, enzymes, and 
regulatory proteins--all of which are coded by the DNA. Any gene for which variation in the 
coding results in an erroneously functioning protein in the meiotic machinery, is a clear 
candidate. With regards to recombination, genes that are associated with recombination 
frequency or pattern are also potential candidates. There has been some identification of such 
genes. Kong et al. (2008) identified the gene RNF212 (ring finger protein) from a genome-wide 
scan for variants associated with recombination rate. Gene ortholog predictions suggest that the 
mammalian RNF212 is similar to the  ZHP-3 gene in Caenorhabditis elegans (roundworm) and 
it is essential for successful recombination between homologous chromosomes (Jantsch et al., 
2004). Parvanov et al. (2010), Baudat et al. (2010), and Myers et al. (2010) found that PRDM9 
(PR domain containing 9) gene controls the extent to which crossovers occur in preferred 
chromosomal locations (known as “hotspots”). Could any of these recombination-related genes 
be responsible for the NDJ in trisomy 21?  
Another group of genes to consider are genes related to the putative accelerated aging 
process among mothers of DS individuals. It has been repeatedly postulated over the years that it 
is the ‘biological age,” not the chronological age, of the mother that is the risk factor for 
aneuploidy in offspring (Emanuel et al., 1972; Brook et al, 1984). This hypothesis would help 
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explain the birth of DS babies among young mothers. Evidence supporting this thought includes 
the high prevalence of grey hair in young mothers of DS children (Emanuel et al., 1972) and 
their fivefold increased risk for Alzheimer’s disease (AD) (Schupf et al., 1994, 2001). Because of 
this relatedness between AD and DS, researchers are reviewing genes responsible for AD among 
mothers of DS children. Avramopoulos et al. (1996) examined the distribution of apolipoprotein 
E (APOE) and found that the frequency of the APOE allele that is susceptible for AD among 
young mothers with M2 error is 30.0%, which is significantly higher than the frequency among 
older mothers with M2 error (13.0%, p-value=0.03). A rare form of early onset AD is caused by 
a mutation in the presenilin-1 (PSEN1) gene (Sherrington et al., 1995). This gene codes for the 
presenilin protein which is localize in the nuclear membrane, kinetochores, and centrosomes 
suggesting that this protein may play a role in chromosome organization and segregation (Li et 
al., 1997). It has also been found that M2 mothers has increased frequency of the AD susceptible 
allele of PSEN1 (70.8%) in comparison to 52.7% in M1 mothers (p-value < 0.01) (Petersen et 
al., 2000). Another AD gene worth considering is the MAPT (microtubule-associated protein 
tau) gene, which codes for the microtubule-associated protein tau that forms the hallmark 
neurofibrillary tangles in AD histology. The MAPT gene is located in a genomic inversion 
region that has been shown to be involved in recombination rate (Zody et al., 2008; Fledel-Alon 
et al., 2011). 
1.2 GENOME-WIDE ASSOCIATION STUDY 
A genome-wide association study (GWAS or GWA study) is an approach that involves rapidly 
scanning genetic markers, usually single-nucleotide polymorphisms (SNPs), across complete sets 
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of DNA, or genomes, of many people to find genetic variations associated with a particular 
disease. Such study is useful in finding potential genes that contribute to common but complex 
diseases such as cancer, diabetes, heart disease and mental illnesses. This type of study became 
possible after the completion of the Human Genome Project in 2003 and the International 
HapMap Project in 2005. The projects accomplished in mapping the entire human genome and 
determined the 3 billion basepair sequences of human DNA identifying approximately 20,000-
25,000 genes (U.S. Department of Energy Genome Program, 2012; The International HapMap 
Consortium, 2003).  
According to the National Human Genome Research Institute (2011), there are about 10 
million common SNPs in the human genome. Scanning this large number of SNPs for the entire 
genome in a large sample of study subjects would be time-and-resource intensive. Fortunately, 
there is a shortcut that can reduce the workload by 30-fold. Upon the completion of the 
International HapMap Project, it was found that those 10 million SNPs form into clusters (called 
“haplotypes”). Because of this clustering, a few SNPs can be selected to represent each cluster 
and the entire genome can be well-represented by simply using as low as 300,000 chosen SNPs 
(The International HapMap Consortium, 2003). 
The most frequently used GWA study design is case-control. The frequencies of each 
genotype (aa, Aa, and AA) of the tested SNP among subjects with the disease of interest are 
compared to the frequencies in those disease-free. The comparison is made for each SNP. Under 
the null hypothesis of no association with the disease, the ratio is similar within each genotype 
group. However, if a particular genotype of the SNP is more frequent in the disease than the 
control group, then that SNP is said to be “associated” with the disease.  
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GWA study is very different from other type of applied statistical research studies.  
Typically statistical studies have an a priori hypothesis being tested and if the topic is genetically 
related, only one or a few genetic regions are being tested. In contrast, GWA study usually does 
not have pre-specified genes to be tested and a large number of statistical tests are being done 
(one for each SNP). Thus GWA study is considered a hypothesis generating study or exploratory 
study. It is not used to established causal relationship. Rather, it identifies potential genetic 
candidates out of the entire genome for future investigation.  
Pearson and Manolio (2008) outlined the parts of a typical GWA study: (1) selecting a 
large number of individuals with the outward characteristic (phenotype) of interest and a suitable 
comparison group; (2) isolating DNA from these individuals, running the genetic assays 
(genotyping), and reviewing the obtained data to ensure high genotyping quality; (3) computing 
the statistical tests for associations between the phenotype and SNPs that has passed set quality 
control thresholds; and (4) replicating putative associations in an independent population sample 
or performing an experiment that would test biologically test for potential causuality. 
A case-control design is often easier and less expensive to conduct than designs such as a 
prospective cohort study. However, this design also carries the most assumptions, which if not 
met, can lead to substantial biases and spurious associations. The assumptions are: (1) case and 
control subjects are drawn from the same population; (2) the sampled case subjects are 
representative of all cases of the disease, else the limitations on diagnostic specificity and 
representativeness are clearly specified; (3) genomic and epidemiologic data are collected 
similarly in cases and controls; and (4) the differences in allele frequencies is due to the outcome 
of interest, not the difference in background between cases and controls (Pearson and Manolio 
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2008). It can clearly be seen from the above list of assumptions that proper sampling of the cases 
and controls are crucial to maintain the validity of the study results. 
1.2.1 Case-Case Genome-Wide Association Study 
The case and the control groups are somewhat arbitrary defined. As such, a novel way to make 
comparisons is to compare a group of one disease type against a group of another disease type, or 
do a “case-case comparison.”  
There are theoretical reasons why comparing between two groups of cases, rather than 
between a case and a control, has benefits. Some advantages are the elimination of selection 
biases and reduced background noise (Curtis et al., 2011). Typically, controls are recruited from 
a different source population than the cases. Cases often are derived from clinical settings 
whereas controls are obtained from a non-clinical setting. There may be unforeseen differences 
between them other than just the disease status. By using only the cases however, all subjects are 
recruited from the same clinical setting. The two case groups might be more similar in terms of 
their geographical background, social class, and factors influencing presentation to services. 
Having well-matched samples reduces background noise and it is expected to increase both the 
power and specificity of the association study.  
By comparing the genome data between two sets of cases, we are able to pick up genetic 
markers that are associated with the differentiation between the two disease groups. Identifying 
genes that divides the disease from the control is medically crucial. However, it is sometimes 
important as well to identify what makes disease D type A different from disease D type B. 
There could be differences in etiology between the two. Perhaps one type is easily preventable, 
curable, or manageable than the other. But we will not be aware of such information if we do not 
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analyze the data in this manner. Of course, the caveat here is that the case-case analysis would 
not be able to identify disease-causing genetic components shared between the two types.  
1.3 THESIS PROJECT 
1.3.1 Overview 
This thesis focuses performs genome-wide association analysis to locate genes that may 
influence the difference in maternal meiosis NDJ errors between M1 and M2. It is a case-case 
analysis, comparing among mothers of DS children. In addition to reducing the background 
noise from examining a more homogenous study sample, there has been compelling evidence 
that the etiology of M1 and M2 NDJ is distinct, and we wish to locate the genetic factors 
potentially responsible for these distinct etiologies. Though this case-case GWA study will 
efficiently pick up genes that are associated with the individual types of NDJ, it will miss any 
genes that are common to both NDJ types.  
As previously mentioned, a GWA study has many parts and many specialized skills are 
required to complete the whole study. Only the data management and statistical analyses aspects 
are completed for the purpose of this thesis project and explicitly described. Sampling of study 
cases and processing of genetic assays were done by another party prior to the start of this 
project.  
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1.3.2 Objective 
Risk factors for maternal NDJ have been identified in past studies to include advanced maternal 
age and altered recombination. While there have been identification of genes likely responsible 
for recombination, there has yet been any study linking between any particular recombination 
genes with NDJ and trisomy 21. Therefore this is a pilot study. It is also exploratory in nature 
due to the application of genome-wide association analysis. There are no pre-defined hypotheses 
to be tested but the direction of the analysis can be stated within two aims:   
Aim1: Is the primary analysis. It involves scanning the entire genome of the study 
sample and identify for any possible genes that may be responsible for the separate etiologies of 
M1 and M2 NDJ.  
Aim2: Utilizing the already analyzed data, we review the five candidate genes 
specifically discussed in section 1.1 above. The five genes candidates are RNF212, PRDM9, 
APOE, PSEN1, and MAPT. The first two genes (RNF212 and PRDM9) are recombination 
genes, while the next two (APOE and PSEN1) are Alzheimer’s disease related genes. MAPT is a 
special case of gene that may be related to both recombination rate and Alzheimer’s disease. 
The importance of understanding the causes of NDJ cannot be over-stated. NDJ in 
general, is the leading cause of pregnancy loss and among, live births--it is the leading genetic 
cause of intellectual and developmental disabilities and birth defects. This thesis project will 
enable us to tease apart the susceptibility of human NDJ into its individual liability factors. 
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2.0  METHODS AND RESULTS 
2.1 STUDY SAMPLE 
2.1.1 Genome-Wide Genotyping 
Genotyping was carried out on biological parents of Down syndrome children. This collection of 
biological assays was a part of HL092981 (Zwick PI) to identify copy-number variations (CNVs) 
that are associated with congenital heart defects among individuals with Down syndrome (Hedge 
et al., 2008). Families were identified through a birth defect surveillance system and included 
live born infants with documented trisomy 21. They were recruited by the Atlanta Down 
Syndrome Project (ADSP, birth years 1989-1999, ascertaining cases from the 5-county 
metropolitan Atlanta area) and the National Down Syndrome Project (NDSP, birth years 2000-
2004, ascertaining cases from 6 national sites). 
DNA samples were genotyped using the Affymetrix® Genome-Wide Human SNP 6.0 
Array chips per Affymetrix standard protocol (Affymetrix, Santa Clara, California, USA). Initial 
quality control (QC) measures were implemented in the Zwick lab. For a sample to pass QC and 
hence be included in the downstream analysis, each sample had to have 86% call rate at the 
minimum, 0.4 contrast quality control and gender concordance, which are all Affymetrix 
recommended parameters. After this initial quality control, there were a total of 383 genotyped 
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samples. The Affymetrix® Genome-Wide Human SNP 6.0 Array contains 906,600 selected 
markers from the entire human genome. Genotype information of the parents was electronically 
stored in the text data file, parents.ped.  
2.1.2 Determining Meiotic Nondisjunction Error ‘Phenotype’ 
The parental source of the third chromosome 21 was determined by examining parental and child 
genotypes on chromosome 21.. This was accomplished using both STR and SNP genotyping 
methods. If a maternal origin was established, then the stage of meiotic error (meiosis I vs. 
meiosis II) was determined using genetic markers located in the pericentromeric region 
(13,615,252 bp - 16,784,299 bp) of 21q. If both maternal chromosomes had the same allele for 
all the aforementioned genetic markers (homozygous), then it was inferred that the error 
happened in meiosis II. If some of the alleles for one maternal chromosome were different than 
the other one (heterozygous), then the error was classified as meiosis I. 
The parental source, stage of meiotic error and race of 187 mothers and 185 fathers (189 
unique families) were stored on a Microsoft Excel spreadsheet named Phenotype Variables.xlsx. 
Note that the number of samples in the genotype data did not exactly match the number of 
parents recorded on the Excel spreadsheet. 
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2.2 DATA MANAGEMENT 
Due to the massive nature of genetic data, it was not easy to simply view the data and check the 
genotype files. Thus this section explains the setup of data storage and how data management 
was accomplished. 
2.2.1 Starting Files 
The PED file, parents.ped, held the actual genotyped data and subject identification variables. 
Information was arranged in 383 lines (for 383 samples) and 1,813,206 columns. The type of 
information and order of the columns had to be arranged in a specific pattern as followed:  
Column1 = Family ID (number ranges from 171002-9915166) 
Column2 = Individual ID [either 10 or 20 (10=father, 20=mother)] 
Column3 = Paternal ID  
Column4 = Maternal ID  
Column5 = Sex (1=male, 2=female) 
Column6 = Phenotype [represented as 1, 2, or 0 (1=unaffected, 2=affected,  
        0=missing)] 
Column7+8 = genotype pair at SNP1 (represented as a pair of bases, one column   
for each allele) 
Column9+10 = genotype pair at SNP2 
… 
Column1813205+1813206 = genotype pair at SNP906600 
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The MAP file, parents.map, was a file to be used concurrently with parents.ped. It 
contained the chromosomal positions of each SNP that has been genotyped in the PED file and 
had following column arrangement: 
Column1 = Chromosome# 
Column2 = rs# (or SNP identifier) 
Column3 = Genetic distance (in morgans) 
Column4 = Physical base-pair position (in bp units) 
The primary outcome for the analysis in this thesis project was the meiosis stage where 
chromosomal nondisjunction had occurred [meiosis I (M1) vs. meiosis II (M2)]. Thus meiosis 
stage was the phenotype of interest in this research. This information, however, was stored 
separately on the Microsoft Excel spreadsheet, Phenotype Variables.xlsx, and it needed to be 
extracted and linked to the genotype files before we ran any statistical analyses. 
The subpopulation used for this project was limited to only Caucasian mothers of Down 
syndrome children whose third 21 chromosome had come from the mother. Family IDs, 
Individual IDs, and phenotype values of 143 Caucasian mothers were extracted from Phenotype 
Variables.xlsx and formatted in the manner below: 
Column1 = Family ID (number ranges from 171002-9915166) 
Column2 = Individual ID [either 10 or 20 (10=father, 20=mother)] 
Column3 = Phenotype [either 1 or 2 (1=M1, 2=M2)] 
The file was saved as meiosis.txt and served as the ‘alternative phenotype’ for the PED/MAP 
files. 
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2.2.2 PLINK 
Because of the magnitude of DNA data, specialized software was needed for the extensive 
computation. PLINK is a free, open-source program designed to perform a range of basic, large-
scale whole genome association analyses (Purcell et al., 2007). The program can be downloaded 
and instructions on how to execute data management-related and analytical tasks can be found at 
http://pngu.mgh.harvard.edu/~purcell/plink/. It was also the primary software package being 
used for this thesis research and it is the standard software for almost all GWA study analysis. 
PLINK is a command-line program written in C/C++ and it is executable via MS-DOS under the 
Windows platform. All commands involve typing plink at the command prompt. Output files are 
in a standard plain text format with various possibilities of file extension names depending on the 
executed command. 
2.2.3 Binary PED File 
While analyses could be directly done using the MAP/PED files, the duo files were instead 
converted into a binary PED file (*.bed) to further cut down computation time by using the 
following PLINK command: 
plink --ped parents.ped.txt --map parents.map --make-bed  
      --out parents 
2.2.4 Merging Genotype and Phenotype Data 
The new genotype BED file was then merged with the meiosis phenotype file. PLINK gave a 
preliminary descriptive statistics of the merged data below. PLINK reported that after matching 
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the IDs between the genotype BED file and alternative phenotype text file, there were only 118 
matched participants. This number was lower than the expected count from the phenotype file. 
plink --bfile parents --pheno meiosis.txt --out merge 
 
Reading alternate phenotype from [ meiosis.txt ]  
118 individuals with non-missing alternate phenotype 
Assuming a disease phenotype (1=unaff, 2=aff, 0=miss) 
Missing phenotype value is also -9 
35 cases, 83 controls and 6 missing 
Before frequency and genotyping pruning, there are 906600 SNPs 
 
In order to figure out why the discrepancy, we executed a missingness query using the 
following command: 
plink --bfile parents --pheno meiosis.txt --missing --out missing 
 
A list of Family IDs and Individual IDs of individuals whose data were missing was generated. 
We noted that there was a mismatch in Individuals IDs. In the phenotype file, all the Individual 
IDs for mothers were coded 20. The output in Table 1 shows that the genotype data have 
duplicate arrays for some individuals. The Individual IDs for them were not recorded as 20, but 
were recorded as a 20 with a tag that signified the duplicated sample. 
Table 1. Output after executing the missing command shows inconsistent recordings of Individual ID 
      FID       IID MISS_PHENO   N_MISS   N_GENO   F_MISS   
  1710033        20          N    10583   906312  0.01168 
  1710034        10          Y    45406   906600  0.05008 
  1710034   20_dup1          Y    24808   906312  0.02737 
  1710034   20_dup2          Y    47716   906312  0.05265 
  1710038        10          Y     7988   906600 0.008811 
  1710038        20          N    12369   906312  0.01365 
  1710042   10_dup2          Y    55953   906600  0.06172 
  1710042   10_dup1          Y    28126   906600  0.03102 
 
FID=Family ID, IID=Individual ID, MISS_PHENO=indicating whether phenotype is missing or not, 
N_MISS=number of missing SNPs, N_GENO=number of non-obligatory missing genotypes,  
F_MISS=proportion of missing SNPs  
 
To solve this discrepancy, Individual IDs for the mothers in the outcome file were 
corrected by us to match with the Individual IDs in the genotype file. Only one genotype data 
was allowed per mother. Therefore, if there were duplicate arrays, we kept only the most recent 
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array in the data set. After this correction, a new phenotype file meiosis2.txt was created. The 
sample size was now at 137 mothers. 
plink --bfile parents --pheno meiosis2.txt --out merge2 
 
Reading alternate phenotype from [ meiosis2.txt ]  
137 individuals with non-missing alternate phenotype 
Assuming a disease phenotype (1=unaff, 2=aff, 0=miss) 
Missing phenotype value is also -9 
42 cases, 95 controls and 246 missing 
Before frequency and genotyping pruning, there are 906600 SNPs 
2.2.5 Per-Individual Quality Control 
To reduce the potential for both false-positive and false-negative associations, quality control 
measures needed to be taken. Per-individual QC is recommended to be performed first before 
conducting QC on a ‘per-marker’ basis to maximize the number of markers remaining in the 
study (Anderson et al., 2010). 
2.2.5.1 Sex Check 
We checked the reported sex of the individuals against their actual genetic data makeup. 
This was done by examining the sex chromosomes. A female has two X chromosomes whereas a 
male has one X chromosome and one Y chromosome. There are many genes unique to the Y 
chromosome. However, a certain region on the Y chromosome called “the pseudo-autosomal 
region” contains genes that are common to both sex chromosomes. Therefore if an individual is 
male, then the genotyping of the Y chromosome area not in the pseudo-autosomal region would 
not be heterozygous (Anderson et al., 2010). 
After running the sex-check command in PLINK, there were 3 individuals that are 
genetically males but were reported as females. Their IDs were 5510067.20, 7210113.20, and 
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9910657.20 as shown in Table 2. Note that a male call is made by PLINK if F is more than 0.8; 
a female call is made if F is less than 0.2 (Purcell et al., 2009). 
plink --bfile parents --pheno meiosis2.txt --check-sex  
      --out sexcheck 
 
Table 2. Output after running sex discordance check shows incorrect recordings of sex  
      FID       IID       PEDSEX       SNPSEX       STATUS            F 
  4710041        10            1            1           OK        0.984 
  4710041        20            1            2      PROBLEM       0.0508      
  5510067        10            1            1           OK       0.9843 
  5510067        20            2            1      PROBLEM       0.9855   
  7210113        20            2            1      PROBLEM       0.9848     
  7210159        10            1            2      PROBLEM        0.104    
  7210159        20            2            2           OK       0.1055 
  9910657        10            1            1           OK        0.986 
  9910657   20_dup3            2            1      PROBLEM       0.9857    
  9910657   20_dup1            2            1      PROBLEM       0.9857    
  9910657   20_dup2            2            1      PROBLEM       0.9858    
 
FID=family ID, IID=individual ID, PEDSEX=the recorded sex in the PED file,  
SNPSEX=sex determined using SNP/genetic data, STATUS=indicate whether there is an error or not,  
F=X chromosome inbreeding (homozygosity) estimate 
 
After this analysis, we imputed the correct sex information and a new BED file was 
generated, parents2.bed. Because the analysis for this project did not involve males, data for IDs: 
510067.20, 7210113.20, and 9910657.20 were removed from the revised alternative phenotype 
file, named meiosis3.txt.   
plink --bfile parents --impute-sex --make-bed --out parents2 
2.2.5.2 Identification of Duplicated or Related Individuals 
The next step was to identify duplicated individuals which were recorded by mistake. For 
each pair of parents within the same family, a kinship metric (identity by state, IBS) was 
calculated based on the average proportion of alleles shared in common at genotyped SNPs 
(excluding the sex chromosomes) (Purcell et al., 2007). The IBS output is displayed in Table 3. 
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Table 3. Output after computing within-family IBS shows a duplicate sample recorded under a different ID 
FID1     IID1     FID2     IID2 RT    EZ      Z0      Z1      Z2  PI_HAT PHE       DST     PPC   RATIO 
4710041       10  4710041       20 OT     0  0.9213  0.0657  0.0130  0.0459  -1  0.785929  0.9997  2.2298 
5510067       10  5510067       20 OT     0  0.9460  0.0166  0.0374  0.0457  -1  0.787197  1.0000  2.2936 
7210159       10  7210159       20 OT     0  0.0000  0.0024  0.9976  0.9988  -1  0.999666  1.0000      NA 
9910657       10  9910657  20_dup3 OT     0  0.9695  0.0000  0.0305  0.0305  -1  0.783736  0.8690  2.0716 
9910657       10  9910657  20_dup1 OT     0  0.9606  0.0302  0.0092  0.0243  -1  0.782070  0.9818  2.1358 
9910657       10  9910657  20_dup2 OT     0  0.9572  0.0322  0.0106  0.0267  -1  0.782549  0.9742  2.1260 
9910657  20_dup3  9910657  20_dup1 OT     0  0.0004  0.0343  0.9653  0.9825  -1  0.995190  1.0000 2393.0000 
9910657  20_dup3  9910657  20_dup2 OT     0  0.0008  0.0363  0.9628  0.9810  -1  0.994807  1.0000 2393.5000 
9910657  20_dup1  9910657  20_dup2 OT     0  0.0007  0.0532  0.9461  0.9727  -1  0.992519  1.0000 1600.3333 
 
FID1=family ID for the first individual, IID1=individual ID for the first individual,  
FID2=family ID for the second individual, IID2=individual ID for the second individual,  
RT=relationship type given PED file, EZ=expected IBD sharing given PED file, Z0=P(IBD=0),  
Z1=p(IBD=1), Z2=P(IBD=2), PI_HAT=P(IBD=2)+0.5*P(IBD=1) or proportional IBD,  
PHE=pairwise phenotypic code (1, 0, -1= AA, AU, and UU pairs),  
DST=IBS distance (IBS2 + 0.5*IBS1)/(N SNP pairs), PPC=IBS binomial test,  
RATIO=of HETHET:IBS 0 SNPs (expected value is 2)  
 
 
The column DST contains the computed IBS distance. Duplicates were defined to have IBS > 
0.98 (Anderson et al., 2010). The output confirmed that the two supposedly distinct individuals 
listed under Family ID 7210159 were actually the same person. Since the ID for 7210159.20 was 
already listed in meiosis3.txt phenotype file, there was no need to make any more changes to it.  
2.2.6 Per-Marker Quality Control  
Per-marker QC essentially involved filtering our genotype data and removing suboptimal 
individuals and SNPs. Individuals that were missing too much genetic data (maximum individual 
missingness rate, MIND) and SNPs that were missing from too many samples (GENO) were not 
able to provide sufficient information in the statistical analyses. In fact, their presence could give 
a false-positive result and mask the true association (Anderson et al., 2010). Because of our small 
sample size, we were willing to accept individuals with up to 10% missing genotype information 
and SNPs with no more than 10% missingness across samples. 
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SNPs that show little variation, for example 1 of out 100 people, are not useful 
statistically and are typically removed from a GWAS analysis. The common standard minor 
allele frequency (MAF) is about 1-2% (Anderson et al., 2010). In this project, a MAF threshold 
of 1% was used. 
Lastly, SNPs that showed extensive deviation from Hardy-Weinberg equilibrium (HWE) 
were excluded because they are typically indicative of a genotype calling error. The threshold for 
this parameter ranges between 0.001 to 5.7 x 10-7 (Anderson et al., 2010). For this project, we set 
the threshold value for HWE to 0.001.  
We filtered the data based on these pre-specified parameters and the following output 
was obtained: 
plink --bfile parents2 --pheno meiosis3.txt --mind 0.1 --geno 0.1  
--maf 0.01 --hwe 0.001 --out summstat 
 
Before frequency and genotyping pruning, there are 906600 SNPs 
0 of 383 individuals removed for low genotyping ( MIND > 0.1 ) 
2240 markers to be excluded based on HWE test ( p <= 0.001 ) 
 895 markers failed HWE test in cases 
 2239 markers failed HWE test in controls 
Total genotyping rate in remaining individuals is 0.977565 
42538 SNPs failed missingness test ( GENO > 0.1 ) 
105229 SNPs failed frequency test ( MAF < 0.01 ) 
After frequency and genotyping pruning, there are 763771 SNPs 
After filtering, 40 cases, 94 controls and 249 missing 
 
Afterwards, we were left with 134 Caucasian mothers. The number of cases of meiosis I and 
meiosis II nondisjunction is summarized in Table 4. Table 5 summarizes the information from 
the per-marker QC. 
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Table 4. Distribution of meiosis I and meiosis II NDJ cases after quality control implementation 
Stage of nondisjunction error Count (%) 
M1 (phenotype=1) 94 (70.15) 
M2 (phenotype=2) 40 (29.85) 
TOTAL 134 
 
 
Table 5. Summary of output after implementing per-marker QC 
 Set parameter Number removed 
Total 
number 
Unit 
Maximum individual missingness 
rate (MIND) 
0.1 0 134 individuals 
Genotyping rate (GENO) 0.1 42538 906600 SNPs 
Minor allele frequency (MAF) 0.01 105229 906600 SNPs 
Hardy Weinberg equilibrium 
(HWE) 
0.001 2240 906600 SNPs 
controls (M1) --- 2239 906600 SNPs 
cases (M2) --- 895 906600 SNPs 
After per-marker QC 
MIND=0.1 
GENO=0.1 
MAF=0.01 
HWE=0.001 
--- 
Total 
remain 
134 
763771 
 
 
individuals 
SNPs 
 
2.3 TEST FOR ASSOCIATION 
2.3.1 Background 
The idea behind association analysis was to look through each SNP one by one, testing to see if 
there was a difference in the frequency of genotypes seen between the two case groups: M1 vs. 
M2. If this difference was statistically significant, then that SNP would be said to be associated 
with the phenotype. The method of statistically testing the frequencies was through a chi-squared 
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test. Under the null hypothesis of no association, we would expect the genotype frequencies 
between the two groups to be the same. 
There are different types of association analyses:  
1. Basic allelic test for association 
The unit of this test is the allele rather than the genotype. A genotype 
consists of two alleles, AA, Aa, or aa. The associations of the phenotype 
with these individual alleles are then tested. This test has the advantage in 
that the sample size would double. However, it is not the best test for 
association in humans as it ignores the overall genotype of the two 
chromosomes. 
2. Genotypic tests 
The units for these tests are the genotypes. 
a. Basic genotypic test 
It is a 3×2 tabulation. There are 3 genotypes--homozygote aa, 
heterozygote Aa, and homozygote AA--and 2 comparison groups 
(case/control or case/case). This test has (2-1)×(3-1) = 2 degrees of 
freedom. The extra degree of freedom means that a larger chi-
squared value is needed to obtain the same p-value in comparison 
to a 2×2 contingency table. However, this is the most basic test 
and makes no assumptions about the genetic model. 
b. Additive model 
This model assumes that having two copies of the minor allele 
(AA genotype) has twice the effect of having a single copy of the 
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minor allele (Aa genotype). This test has 1 degree of freedom. It is 
also known as the ‘Cochran-Armitage test for trend.’ 
c. Dominant Model 
This model assumes that an effect on phenotype is only seen if you 
have at least one copy of the minor allele (either genotype Aa or 
AA). This test also has 1 degree of freedom. 
d. Recessive model  
This model assumes that an effect on phenotype is only seen if you 
have two copies of the minor allele (genotype AA only). This test 
also has 1 degree of freedom. 
It is recommended that if the underlying genetic model is unknown, then the additive model 
should be used (Clarke et al. 2011). Kuo and Feingold (2009) discussed in their paper that 
recessive and dominant loci are quite rare in whole genome-scanning and the model with the best 
statistical power is an intermediate between the recessive model and dominant model--the 
additive model. For these reasons, the type of model selected for our association analysis is the 
additive model or the Cochran-Armitage test for trend. 
Table 6 below illustrates how the genetic information is grouped for statistical analysis. 
For each SNP, the number of the minor allele A is counted from the subject’s genotype (the 
subject’s genotype can only be one of the following: AA, Aa, or aa). If the subject has genotype 
aa, then the number of minor allele is determined to be 0. If, however, the subject has genotype 
Aa, then the number of minor allele is determined to be 1, and so on. 
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Table 6. 2x3 genotype-based table 
 
The general format of the test statistic is  
 
where xi are weights. For the Cochran-Armitage test for trend trend, it specifically has a weight 
of x=(0, 1, 2). The second line of equation 1 shows the equation after this specific weight has 
been applied. The null hypothesis can be expressed as: 
H0: All entries in the table are proportional              or 
 
This test statistic has the expected value  
 
and variance under the H0 of 
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Therefore the Cochran-Armitage trend test statistic is 
 
 
which follows the χ2 distribution of 1 degrees of freedom (Cochran, 1954; Armitage, 1955; Kuo 
and Feingold, 2010). 
2.3.2 Association Analysis 
The Cochran-Armitage test for trend was used to analyze the genetic data. Per-marker QC was 
done concurrently with the statistical procedure. 
plink --bfile parents2 --pheno meiosis3.txt --mind 0.1 --geno 0.1 
      --maf 0.01 --hwe 0.001 --model --adjust --model-trend  
      --out assoctest 
 
The output from the trend test was generated as a text file, 
assoctest.model.trend.adjusted. The output was later opened using Microsoft Excel and sorted in 
ascending order by their unadjusted p-values (UNADJ). Table 7 lists the first 20 significant 
SNPs. 
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Table 7. Output from the Cochran-Armitage test for trend 
 
CHR SNP UNADJ GC BONF HOLM SIDAK_SS SIDAK_SD FDR_BH FDR_BY
7 rs1404414 2.45E-06 2.73E-06 1 1 0.841 0.841 0.7285 1
4 rs6854711 3.90E-06 4.32E-06 1 1 0.9463 0.9463 0.7285 1
7 rs2691616 4.16E-06 4.61E-06 1 1 0.9559 0.9559 0.7285 1
2 rs11896348 6.95E-06 7.65E-06 1 1 0.9945 0.9945 0.7285 1
7 rs4316058 7.76E-06 8.54E-06 1 1 0.997 0.997 0.7285 1
7 rs2723497 8.25E-06 9.07E-06 1 1 0.9979 0.9979 0.7285 1
7 rs1830006 9.65E-06 1.06E-05 1 1 0.9993 0.9993 0.7285 1
7 rs2691609 9.78E-06 1.07E-05 1 1 0.9993 0.9993 0.7285 1
7 rs10282707 1.00E-05 1.10E-05 1 1 0.9994 0.9994 0.7285 1
7 rs6973480 1.14E-05 1.25E-05 1 1 0.9998 0.9998 0.7285 1
12 rs10850232 1.23E-05 1.35E-05 1 1 0.9999 0.9999 0.7285 1
12 rs1559836 1.23E-05 1.35E-05 1 1 0.9999 0.9999 0.7285 1
7 rs4543433 1.33E-05 1.46E-05 1 1 1 1 0.7285 1
15 rs17205701 1.36E-05 1.49E-05 1 1 1 1 0.7285 1
14 rs17099861 1.64E-05 1.79E-05 1 1 1 1 0.8042 1
9 rs13286734 1.72E-05 1.88E-05 1 1 1 1 0.8042 1
17 rs7207659 2.20E-05 2.40E-05 1 1 1 1 0.8929 1
7 rs4142995 2.22E-05 2.42E-05 1 1 1 1 0.8929 1
7 rs11768866 2.26E-05 2.47E-05 1 1 1 1 0.8929 1
7 rs6970593 2.56E-05 2.79E-05 1 1 1 1 0.9597 1  
CHR=chromosome number, SNP=SNP identifier, UNADJ=unadjusted p-value,  
GC=genomic-control corrected p-value, BONF=Bonferroni single-step adjusted p-value,  
HOLM=Holm (1979) step-down adjusted p-value, SIDAK_SS=Sidak sinle-step adjusted p-value,  
SIDAK_SD=Sidak step-down adjusted p-value,  
FDR_BH=Benjamin & Hochberg (1995) step-up false discovery rate control,  
FDR_BY=Benjamin & Yekutieli (2001) step-up false discovery rate control 
2.3.3 Multiple Testing 
Because of the multiple association tests being done, one for each SNP, controlling for multiple 
comparisons should be heavily considered. Type I error is the probability of wrongly rejecting 
the null hypothesis when the null hypothesis itself is actually true. It is also termed “the false-
positive rate.” The conventional p-value of <0.05 used as the threshold of level of significance 
cannot be applied to this type of study. If so, an association study of 1 million SNPs will only 
result in 50,000 SNPs being associated with the difference in phenotype. This interpretation of 
the output is not very helpful. 
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Both Bonferroni and Sidak adjusting methods are very conservative and assume 
independence. Holm is a correction method similar but less stringent to the former two. Another 
method, the false discovery rate (FDR) procedure, controls for the expected proportion of false 
positives among significant SNPs (Clarke et al. 2011). In GWA studies, the most commonly 
used correction method is still the Bonferroni method (Pearson et al., 2008). Journals tend to 
accept GWAS findings at the 5×10-7 and sometimes even at the 5×10-8 significance level 
(Clarke et al. 2011). 
However, all of these aforementioned methods do not account for the dependence among 
SNPs (Clarke et al. 2011). SNPs that are near one another are correlated. In addition, this project 
was a pilot study examining potential genetic candidates accountable for the difference in the 
nondisjunction stage. The sample size of this study was very small as well, with 94 M1 cases vs. 
40 M2 cases. Applying the stringent p-value of 5×10-8 or even 5×10-7, would dismiss any 
potential genetic markers that may truly affected the meiosis mechanism. 
2.3.4 Manhattan Plot 
A Manhattan plot is a type of scatter plot used to display data with a large number of data points. 
In a GWA study, the SNP location is displayed on the x-axis while the y-axis displays the -log10 
of the p-value for that SNP. Therefore the stronger the association, for example p-value = 10-7, 
the higher the negative log value will be (e.g. 7).   
Haploview is a bioinformatics software designed to plot data from statistical genomic 
studies. gPLINK conveniently links the analyzing capacity of PLINK with the visualizing 
capacity of Haploview. gPLINK was launched within PLINK by using the command 
Java -jar gPLINK.jar 
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and the output file, assoctest.model.trend.adjusted, was selected in the menu box. After hitting 
the ‘Plot’ button, -log10 transformed unadjusted p-values (UNADJ) were selected to be plot on 
the y-axis. Figure 1 is the obtained Manhattan plot. 
 
 
Figure 1. Manhattan plot of -log (P values) using Haploview 
 
The plot conveniently allows us to see if there are multiple associations within a small 
genomic region. The highest blue dot represents the most significant SNP, rs1404414, which is 
located on chromosome 7. Note that there are many other SNPs on chromosome 7 that have very 
small p-values, as small as the p-value of rs1404414. This grouping effect is due to the 
correlation among nearby SNPs and it is termed “linkage disequilibrium.”  
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2.3.5 Quantile-Quantile Plot 
A quantile-quantile plot (QQ plot) serves as a diagnostic tool for checking the type I error. It 
plots the observed -log10 p-values against the expected -log10 p-values under the null model. 
The expected p-values under the null follow a uniform distribution. If all points fall on the 
diagonal line, then none of the observed p-values are different from the expected ones. This 
would mean that there is no association. 
 
Figure 2. QQ plot of -log10 (P value) using R 
 
The obtained quantile-quantile plot in Figure 2 shows that most of the points fall on the diagonal 
line. There is a little deviation at the top right corner which is expected when there is an 
association between SNPs and the phenotype of our interest.  
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2.3.6 LocusZoom 
LocusZoom is a tool available on the web to plot association results from GWAS and scan to see 
if any of the SNPs landed on any actual biological genes. Being able to identify the genes that 
are involved solidifies the association further and it suggests explainable biological mechanism. 
There are two gene scanning methods that we are utilizing. First we scan for genes near the most 
significant SNP, rs1404414. In the second method, we scan the output in the area of five 
prechosen genes that we suspect might be associated with DS. 
2.3.6.1 Scanning for Potential Gene Candidates 
The output file, assoctest.model.trend.adjusted, is first compressed using SecureZIP® for 
Windows and it is being uploaded to https://statgen.sph.umich.edu/locuszoom/genform.php?type 
=yourdata.  
The information fields were set to accommodate PLINK data. A slight adjustment is 
being made where the P-value Column Name is specified to be UNADJ. The Specify Region to 
Display is SNP rs1404414. Figure 3 shows the LocusZoom plot for rs1404414.  
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Figure 3. Regional plot of area surrounding rs1404414 of -log (P values) using LocusZoom 
 
The top significant p-values belong SNPs located on the region of the gene SNX13. 
Another cluster of SNP with a slightly higher p-values seem to fall near gene PRPS1L1. Another 
LocusZoom plot was obtained. This time the Specify Region to Display was Gene prps1l1. 
Figure 4 shows obtained plot for this gene. 
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Figure 4. Regional plot of area surrounding PRPS1L1 of -log (P values) using LocusZoom 
 
2.3.6.2 Scanning for Association with Candidate Down Syndrome Genes 
The p-values from the trend test were used to examine for possible association with five genes 
that are candidates for association with Down syndrome. These genes are RNF212, PRDM9, 
APOE, PSEN1, and MAPT. The regional plots of the p-values for these five genes are shown in 
Figure 5 - Figure 9. They were obtained by simply switching gene names under the Specify 
Region to Display to each of the five genes listed above. 
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Figure 5. Regional plot of area surrounding RNF212 of -log (P values) using LocusZoom 
 
 
Figure 6. Regional plot of area surrounding PRDM9 of -log (P values) using LocusZoom 
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Figure 7. Regional plot of area surrounding APOE of -log (P values) using LocusZoom 
 
 
Figure 8. Regional plot of area surrounding PSEN1 of -log (P values) using LocusZoom 
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Figure 9. Regional plot of area surrounding MAPT of -log (P values) using LocusZoom 
 
RNF212 regional plot has the highest -log p-value (in other words, the lowest p-value) among 
the five plots. This is followed by PSEN1 regional plot. Clustering of correlated data points can 
be observed in these two plots whereas data points in APOE and MAPT regional plots show no 
pattern. The regional plot of PRDM9 shows a slight clustering and the p-value of the highest 
point does not even reach the 10-2 or 0.01 level. 
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3.0  DISCUSSION 
3.1 SAMPLE SIZE AND DATA QUALITY 
The final sample size of the study was 134 Caucasian mothers who passed on the extra 
chromosome 21 to their DS children. Of these 134, 94 (70%) of them had an NDJ error of 
chromosome 21 during meiosis I and the remaining 40 mothers (30%) had the NDJ error during 
meiosis II. The distribution of these cases agrees with past data (Sherman et al, 2005). This 
sample size is considered relatively low for a GWA study. However, this was expected and 
unavoidable given that we were a previously-collected study sample to analyze a new pilot 
research question. Nevertheless, the data had some positive qualities with regards to reducing 
confounding effects and we were able to identify suggestive candidate genes for NDJ of trisomy 
21 and provide supporting evidence for some candidate NDJ-related genes via recombination or 
AD.  
Of course due to the small sample size, statistical power was consequently relatively low 
and the significance of the evidence for association with the identified SNPs is lower than the 
standard genome-wide significance using Bonferroni correction method of 5×10-8 (Pearson and 
Manolio, 2008). On the other hand, we had some advantages from using a homogenous cohort of 
individuals. Both M1 and M2 cases were recruited from the same place using the same data 
collection method and researchers were not aware of the particular case outcome of each 
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individual until the genetic data had already been collected and assayed in lab. It could be said 
that one positive quality of our data despite the sample size was the reduced background noise 
and confounding effect. This could be confirmed by the QQ plot in Figure 2. The plot shows the 
expected distribution of the association test statistics (x-axis) across the million SNPs compared 
to the observed values (y-axis). Any deviation from the X=Y line implies a consistent difference 
between cases and controls (or between cases 1 and cases 2) across the whole genome. Our QQ 
plot was remarkably ideal showing not a lot of deviation from X=Y line until reaching towards 
the right-hand end, where the deviation from the X=Y line represents the difference between the 
M1 and M2 cases implying a true association of the SNPs with NDJ. 
The believability of the association between significant SNPs and NDJ lies within the 
quality of our genotype data. After tremendous effort being put in quality control, we arrived 
with quite clean genotype data. Good QC should filter out artifacts thus allowing the true 
association to show through. The Manhattan plot, in addition to being used to identify the 
location of significance SNPs, could be used to assess the quality of the genotype data and 
believability of the association. The association would be questionable if the dots representing 
each SNP were quite scattered about despite locating quite high on the y-axis (having very low 
p-values). We were satisfied to find that our data had good genotype quality. Our Manhattan plot 
in Figure 1 showed neat clustering of SNPs for each chromosome and an obvious peak formed 
by significant SNPs on chromosome 17 with nearby correlated SNPs showing similar signal 
strength.  
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3.2 SIGNIFICANT GENES 
3.2.1 Genome-Wide Exploration 
This genome-wide case-case study identified several SNPs on chromosome 7 having lowest p-
values--the lowest at 2.45x10-6 (rs1404414; see Table 7). This SNP did not meet the “genome-
wide” significance threshold as previously mentioned in section 3.1. Nevertheless, this SNP was 
found to be correlated (r2 > 0.8) with several other low p-value SNPs clustering in one localize 
region, the SNX13 gene (see Figure 3). This pattern suggested a probable finding, not simply an 
artifact that happened to have the lowest p-value. If the data set had not been limited to a small 
number of cases, then this SNP would likely have been significant. The association between 
SNX13 and NDJ could not be concluded with enough statistical significance. However, we could 
say that there was a suggested association with the SNX13 gene that we could further explore 
about.  
The purpose of this study was to identify genetic markers for meiotic NDJ and 
hypothesize the involvement of such genes with NDJ error. Therefore, we examined the 
characteristics of SNX13. SNX13 gene (also previously known as RGS-PX1 gene) codes for the 
sorting nexin 13 protein which has both a PHOX and a RGS protein domains thus making it a 
member of both the sorting nexin (SNX) protein family and the regulator of G protein signaling 
(RGS) family. Sorting nexin is a large group of proteins localize in the cytoplasm and interact 
either with the cell membrane directly through their phospholipid-binding PX domain or with 
protein complexes on the cell membrane through protein-protein interaction (Worby and Dixon, 
2002). G proteins, on the other hand, are a family of protein involved in transmitting chemical 
signal originating from outside the cell inside the cell (Zheng et al., 2001). Because of this 
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duality, this protein locating within the endosomes may serve as a link between protein signaling 
and vesicular trafficking (Zheng et al, 2001; Worby and Dixon, 2002). Unfortunately, there has 
been no knowledge of SNX13 involvement with NDJ or meiosis in general. We could only 
speculate how SNX13 could be related to NDJ error. Perhaps among those with a particular NDJ 
type, SNX13 erroneously could not function its usual role in signal transmission or protein 
trafficking that eventually leads to NDJ during one of the meiosis stage. 
While the most significant SNPs was in the SNX13 gene region, we could not ignore the 
correlation (0.2 < r2 <0.6; see Figure 4) with its neighboring gene, phosphoribosyl 
pyrophosphate synthetase 1-like 1 (PRPS1L1), and discount the potential significance of the 
latter gene. PRPS1L1 is 86K basepairs away from SNX13 based on the information available on 
the Epigenomics database (NCBI, 2012). This gene (recall that it is located on the autosomal 
chromosome 7) is related to the PRPS1 and PRPS2 genes of the X chromosome (Taira et al., 
1989). The protein that PRPS1L1 encodes is highly homologous to  
phosphoribosylpyrophosphate synthetase encoded by PRPS1 and PRPS2. These enzymes 
altogether convert the nitrogenous bases (pyrimidine and purine) to their corresponding 
nucleotides in the making of mRNA, although the involvement of the PRPS1L1 in this function 
has only been observed in the testis so far (Taira et al., 1990). The same study found an 
association of this gene with chromosome deletion(Taira et al., 1990). However, there has been 
no further studies on PRPS1L1 to confirm or deny this relationship. Similar to the circumstance 
with SNX13, we could only speculate the involvement of PRPS1L1 with NDJ that perhaps a 
malfunction of the enzyme (wrong conversion of nucleotides or deleting some other important 
chromosome segments) somehow leads to NDJ in one of the meiosis stage.  
 39 
The design of our case-case study allowed us to avoid selection biases and maximize the 
association between SNPs and NDJ. There were still limitations as in all other GWA studies. 
One in particular was the potential for a false-positive association (Pearson and Manolio, 2008). 
The association between NDJ and SNX13 (or PRPS1L1) could be true but it could be false as 
well. This is not saying that completing this study was not fruitful. The benefit of a GWA study 
is the narrowing down of genes from the entire human genome to a few ones that we could 
subsequently focus our effort and verify in a follow-up study. Other limitations of this study in 
particular was the small sample size and the significance of the association not meeting the 
Bonferroni-adjusted threshold recommended for all GWA studies (Pearson and Manolio, 2008). 
As such, additional genotyping of a larger sample of NDJ cases should be subsequently done to 
confirm and prove the significance of the relationship between SNX13/ PRPS1L1 and difference 
in M1 and M2 NDJ etiologies. 
3.2.2 Recombination and Alzheimer ’s Disease Genes 
In comparing the results from the Cochran-Armitage test for trend with the five gene candidates 
of RNF212, PRDM9, APOE, PSEN1, and MAPT, we utilized a different significant p-value 
threshold. For this analysis we were no longer making comparisons among 10 million SNPs. 
Rather, we made comparisons among a smaller subset of SNPs--those that made up the five 
candidate genes. A different p-value threshold needed to be constructed instead of using the 
genome-wide threshold of 5×10-8. The new p-value threshold was computed by utilizing the 
simple and most conservative Bonferroni correction method. 
The Bonferroni correction for multiple comparisons is given in equation 6 below 
(Bonferroni, 1935, 1936). It gives the new p-value threshold (αe) to be applied given a pre-
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determined point-wise (or single test) threshold (αp) and the number of independent comparisons 
being made (N). 
   
We approximated that the number of SNPs per gene to be no more than 15. Therefore there were 
15 SNPs/gene × 5 genes = 75 SNPs being tested. Using a point-wise p-value of 0.05, the 
Bonferroni-corrected p-value for this particular testing is then 0.05/75 ≈ 0.000667. In other 
words, the p-value for determining significance of the five candidate genes would approximately 
be between 5×10-4 and 10-4. Note that we could be a little liberal with the number due to the pilot 
nature of this study. 
SNPs in the RNF212 and PSEN1 regional plots both showed linkage clustering and had 
p-values meeting this constructed threshold (see Figure 5 and Figure 8). While the SNPs were 
not exactly located on the RNF212 and PSEN1 genes, the significant SNPs were near these gene 
regions enough to suspect RNF212 and PSEN1 involvement due to the highly correlated nature 
of genes within the same neighborhood. As previously discussed in section 1.1, RNF212 was 
found to affect recombination rate (Kong et al., 2008). M1 NDJ and M2 NDJ cases had different 
recombination rate; M1 had reduced to no recombination (Lamb et al., 1996, 1997, 2005). 
PSEN1 was a gene, in which its mutation was observed among a rare form of early onset AD 
(Sherrington et al., 1995). This gene was also thought to be involved in chromosome 
organization and segregation (Li et al., 1997). Petersen et al. (2000) found increased frequency of 
PSEN1 susceptible allele among M2 cases and that difference in distribution was reflected in our 
discovery of possible association between PSEN1 and meiotic NDJ of trisomy 21.  
The obtained regional plots for RNF212 and PSEN1 were not perfect--the significant 
SNPs not being located exactly on each respective gene region. Probable explanations for the 
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imperfection included the small sample size of subjects and the type of genotype assay chips 
being used. We could not iterate enough the importance of a follow-up study to verify the 
findings from this project using a much larger sample size. A systemic way of genotyping the 
collect data using different kinds of assay chips could also be attempted. 
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